Unique peptides represent the emerging frontier in drug discovery. Such small structures of building acids present remarkable potential for interacting with difficult pathways involved in various illnesses. Preliminary investigations demonstrate they can deliver specific binding and demonstrate promising pharmacokinetic properties, paving doors to